Work

Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option

Year: 2023

Type: editorial

Abstract: Intrapericardial lncRNA-TARID therapy mitigates myocardial fibrosis. The figure was designed by using BioRender.com.

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehad058

Authors: Xuekun Wu, Francesca Vacante, Joseph C Wu

Institutions: Stanford Medicine, Stanford Cardiovascular Institute, Stanford University

Language: English

Topic: Cardiac Fibrosis and Remodeling

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy, Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs, Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens, Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy

OpenAlex ID: W4327682020

Cites: 15

Cited by: 1

Related to: 10